<p>Co-trimoxazole Preventive Therapy among TB-HIV co-infected patients in Addis Ababa, Ethiopia, August 2011.</p
Background: Mycobacterium tuberculosis (TB) is the most common cause of bacterial infection in human...
The association between Advanced WHO clinical stage and TB/HIV co-infection in Ethiopia.</p
Determinants of occurrence of TB disease in study patients in Ethiopia during and after isoniazid pr...
<div><p>Background</p><p>Collaborative TB/HIV management is essential to ensure that HIV positive TB...
BACKGROUND: Collaborative TB/HIV management is essential to ensure that HIV positive TB patients are...
Co-trimoxazole reduces mortality in HIV-infected adults with tuberculosis (TB), and in vitro data su...
Co-trimoxazole reduces mortality in HIV-infected adults with tuberculosis (TB), and in vitro data su...
Co-trimoxazole (fixed-dose trimethoprim-sulfamethoxazole) is a broad-spectrum antibiotic used to pre...
Background: Globally, HIV and tuberculosis (TB) are a leading cause of death if they occur as co-mor...
Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in developin...
In Thyolo district, Malawi, an operational research study is being conducted on the efficacy and fea...
Tuberculosis (TB) is a leading morbidity and mortality, and the first presenting sign in majority of...
Purpose: Cotrimoxazole preventive therapy (CPT) is a feasible, inexpensive, and well-tolerated way o...
The Pooled prevalence of TB/HIV co-infection among different regions in Ethiopia/sub group Analysis....
Antiretroviral therapy (ART) is the main intervention needed to reduce morbidity and mortality and t...
Background: Mycobacterium tuberculosis (TB) is the most common cause of bacterial infection in human...
The association between Advanced WHO clinical stage and TB/HIV co-infection in Ethiopia.</p
Determinants of occurrence of TB disease in study patients in Ethiopia during and after isoniazid pr...
<div><p>Background</p><p>Collaborative TB/HIV management is essential to ensure that HIV positive TB...
BACKGROUND: Collaborative TB/HIV management is essential to ensure that HIV positive TB patients are...
Co-trimoxazole reduces mortality in HIV-infected adults with tuberculosis (TB), and in vitro data su...
Co-trimoxazole reduces mortality in HIV-infected adults with tuberculosis (TB), and in vitro data su...
Co-trimoxazole (fixed-dose trimethoprim-sulfamethoxazole) is a broad-spectrum antibiotic used to pre...
Background: Globally, HIV and tuberculosis (TB) are a leading cause of death if they occur as co-mor...
Co-trimoxazole is an inexpensive, broad-spectrum antimicrobial drug that is widely used in developin...
In Thyolo district, Malawi, an operational research study is being conducted on the efficacy and fea...
Tuberculosis (TB) is a leading morbidity and mortality, and the first presenting sign in majority of...
Purpose: Cotrimoxazole preventive therapy (CPT) is a feasible, inexpensive, and well-tolerated way o...
The Pooled prevalence of TB/HIV co-infection among different regions in Ethiopia/sub group Analysis....
Antiretroviral therapy (ART) is the main intervention needed to reduce morbidity and mortality and t...
Background: Mycobacterium tuberculosis (TB) is the most common cause of bacterial infection in human...
The association between Advanced WHO clinical stage and TB/HIV co-infection in Ethiopia.</p
Determinants of occurrence of TB disease in study patients in Ethiopia during and after isoniazid pr...
DOI
Add to ORKG